In addition, the upregulated expression of COL18A1 was found in bladder cancer patients with tumor stages T1 and T2, which may be involved in the progression of bladder cancer by affecting extracellular matrix-receptor interactions and adhesion sites [30]. Here, COL18A1 is linked to urinary bladder carcinoma.